| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/03/2004 | EP1392204A2 Bifunctional energy-reversible acyl-compositions |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1109571B1 Methods of treating salt-dependent hypertension |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies |
| 03/03/2004 | EP0633929B1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| 03/03/2004 | CN1479871A Diagnostic and theraputic methods based on L1 adhesion molecule for ovarian and endometrial tumors |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479749A Polysaccharide compound having immune stimulating activity |
| 03/03/2004 | CN1479638A Improvement of graft acceptance through manipulation of thymic regeneration |
| 03/03/2004 | CN1479632A Complexes for transferring necleic acids into cells |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 03/03/2004 | CN1478549A Recombination protein for preventing human trachoma bedsnia infestation and its use |
| 03/03/2004 | CN1140627C Recombinant virus of human vascular endothelial growth inhibitor |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/03/2004 | CN1140170C Concatenated monoclonic antibody medicine for treating fish diseases |
| 03/02/2004 | US6699974 Reshaped human anti-HM 1.24 antibody |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699883 Antibiotics, bactericides, antitumor |
| 03/02/2004 | US6699678 Chlamydia trachomatis specific peptides and their use in diagnostic assays |
| 03/02/2004 | US6699674 Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699664 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 03/02/2004 | US6699657 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 03/02/2004 | US6699483 Cancer treatments |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699480 Vaccine compositions |
| 03/02/2004 | US6699479 Recombinant newcastle disease virus as an embryo vaccine |
| 03/02/2004 | US6699478 Does not induce enhanced disease (e.g., atypical pulmonary inflammation) |
| 03/02/2004 | US6699477 EBV CTL epitopes |
| 03/02/2004 | US6699476 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 03/02/2004 | US6699475 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/02/2004 | US6699473 Human anti-epidermal growth factor receptor single-chain antibodies |
| 03/02/2004 | US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016803A2 Method of enhancing cd4+ t cell responses |
| 02/26/2004 | WO2004016801A2 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016763A2 Treatment of holocrine gland dysfunction with clostridia neurotoxins |
| 02/26/2004 | WO2004016750A2 FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 02/26/2004 | WO2004016743A2 Culturing anaplasma |
| 02/26/2004 | WO2004016643A2 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 02/26/2004 | WO2004016285A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016282A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 02/26/2004 | WO2004016281A1 Intradermal influenza vaccine compositions containing an adp-ribosylating factor |
| 02/26/2004 | WO2004016280A1 Recombinant bcg vaccine |
| 02/26/2004 | WO2004016231A2 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA) |
| 02/26/2004 | WO2004016230A2 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 02/26/2004 | WO2004016228A2 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS |
| 02/26/2004 | WO2004016222A2 Hepatitis c viral-like particle purification |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004004763A3 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 02/26/2004 | WO2004003009A3 Francisella tularensis immunogenic proteins and dna encoding these |
| 02/26/2004 | WO2004000881A9 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 02/26/2004 | WO2003099211A3 Mitotic kinesin inhibitors |
| 02/26/2004 | WO2003098223A3 A method for killing cells by inhibiting histone activity in the cell |
| 02/26/2004 | WO2003097688A3 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/26/2004 | WO2003091387A9 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/26/2004 | WO2003089590A3 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087327A3 Preservation of bioactive materials by freeze dried foam |
| 02/26/2004 | WO2003086296A3 Treatment for type 1 diabetes before and after expression of predisposition markers. |
| 02/26/2004 | WO2003082209A3 Cochleates made with purified soy phosphatidylserine |
| 02/26/2004 | WO2003079978A3 Protease activity of thrombin inhibits angiogenesis |
| 02/26/2004 | WO2003074003A3 Immunogens for treatment of neoplastic and infectious disease |
| 02/26/2004 | WO2003066813A3 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 02/26/2004 | WO2003062401A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059953B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057822A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 02/26/2004 | WO2003033530A3 Mycobacterial antigens expressed under high oxygen tension |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003025566A3 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003000232A3 Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002099047A3 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | WO2002095005A3 Therapeutic dna vaccination |
| 02/26/2004 | WO2002092012A9 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002083890A3 Use of clya hemolysin for excretion of fusion proteins |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002083058A3 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |